GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:
wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
本发明公开了GnRH受体拮抗剂,其在治疗男性和女性的各种性激素相关疾病中具有用途。本发明的化合物具有以下结构:其中R1a、R1b、R1c、R1d、R2、R2a和A的定义如本文所述,包括立体异构体、
酯类、溶剂化物和其药学上可接受的盐。本发明还公开了含有本发明化合物与药学上可接受的载体组合的组合物,以及与拮抗需要拮抗性腺激素释放激素的方法有关的使用方法。